SouthState Corp’s ResMed RMD Stock Holding History

SouthState Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.04K	Hold	18	–	–	﹤0.01%	787
2025 Q4	$4.34K	Sell	18 -2	-10%	-$511	﹤0.01%	831
2025 Q3	$5.47K	Sell	20 -47	-70%	-$12.8K	﹤0.01%	749
2025 Q2	$17.3K	Sell	67 -17	-20%	-$4.05K	﹤0.01%	684
2025 Q1	$18.8K	Buy	+84	New	+$19.6K	﹤0.01%	704
2024 Q3	–	Sell	-13	Closed	-$2.49K	–	638
2024 Q2	$2.49K	Sell	13 -278	-96%	-$56.4K	﹤0.01%	583
2024 Q1	$57.6K	Buy	+291	New	+$53.3K	﹤0.01%	360

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SouthState Corp's RMD Position: Q1 2026 in Review

SouthState Corp held its ResMed (RMD) position steady in Q1 2026 at 18 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

SouthState Corp first reported a position in RMD in Q1 2024 and has held it in 7 quarters since. The position peaked at $57.6K in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

SouthState Corp held 18 shares of ResMed worth $4.04K as of Q1 2026.
SouthState Corp left its ResMed share count unchanged in Q1 2026.
ResMed made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #787 holding.
SouthState Corp first reported a position in ResMed in Q1 2024 and has held it in 7 quarters since.
SouthState Corp's ResMed position peaked at $57.6K in Q1 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.